AstraZeneca Pharmaceuticals LP is the U.S. affiliate of AstraZeneca, a large biopharmaceutical company. It lobbies on health-care and drug-policy issues, including Medicare and Medicaid rules, pharmacy matters, drug pricing and negotiation, electronic labeling for prescribing information, and manufacturing and tariff concerns. Filings show $5.1 million reported across four filings through 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CAROLINE QUAT
The latest disclosures for this client.
ASTRAZENECA PHARMACEUTICALS LP
Q2ASTRAZENECA PHARMACEUTICALS LP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
ASTRAZENECA PHARMACEUTICALS LP
KATIE JONES
ASTRAZENECA PHARMACEUTICALS LP
LISA LANGENDERFER
ASTRAZENECA PHARMACEUTICALS LP
mrs SARAH CUDWORTH ARBES
ASTRAZENECA PHARMACEUTICALS LP
ART MOTTA
ASTRAZENECA PHARMACEUTICALS LP
EMILY MACE
ASTRAZENECA PHARMACEUTICALS LP
BAILEY MCCUE
ASTRAZENECA PHARMACEUTICALS LP
TALEEN MEKHDJAVAKIAN
ASTRAZENECA PHARMACEUTICALS LP
ASTRAZENECA PHARMACEUTICALS LP
Q4ASTRAZENECA PHARMACEUTICALS LP
Q3ASTRAZENECA PHARMACEUTICALS LP
Q2ASTRAZENECA PHARMACEUTICALS LP
Q1